Clinical Trials in Maryland

Showing 21441-21460 of 23,284 trials

TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors

NCT00356980

RATIONALE: Biological therapies, such as TNF-bound colloidal gold, may stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is studying the side effects and best dose of TNF-bound colloidal gold in treating patients with advanced solid tumors.

Unspecified Adult Solid Tumor, Protocol Specific

National Institutes of Health Clinical Center (CC)60 participantsStarted May 2006

Bethesda, Maryland, United States • Bethesda, Maryland, United States

COMPLETEDPhase 117 miles

ABT-751 in Treating Young Patients With Refractory Solid Tumors

NCT00036959

RATIONALE: Drugs used in chemotherapy, such as ABT-751, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects of ABT-751 in treating young patients with refractory solid tumors.

Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more

National Institutes of Health Clinical Center (CC)90 participantsStarted Mar 2002

Chicago, Illinois, United States • Bethesda, Maryland, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 117 miles

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

NCT00019019

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of carboxyamidotriazole and paclitaxel in treating patients with advanced solid tumors or refractory lymphomas.

Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more

National Institutes of Health Clinical Center (CC)70 participantsStarted Oct 1994

Bethesda, Maryland, United States • Bethesda, Maryland, United States

TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Find Trials by Condition in Maryland

Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

ETEC Logistics Trial (TREK)

Resolution of Comorbidities, Safety and Efficacy of Greater Curvature Plication in Obese Patients.

Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Study of Daclizumab in Patients With Chronic, Persistent Asthma

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study